Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05517928 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis

A NA study of Healthy, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05517928: Recruiting NA study of Healthy, sponsored by Mayo Clinic.

NCT05517928 is a NA study of Healthy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05517928, a NA study of Healthy, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the impact of the probiotic Lactobacillus rhamnosus (LGG) on proton pump inhibitor (PPI)-induced changes to the microbes that live in the gastrointestinal tract and are passed out in the stool. PPI medicines reduce stomach acid and are commonly used to treat acid reflux disease.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Omeprazole
  • DIETARY_SUPPLEMENT Lactobacillus rhamnosus GG

Study Locations (1)

Arizona

  • Mayo Clinic Arizona - Scottsdale

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-03-03
Est. Completion 2026-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05517928

The ClinicalTrials.gov registry entry for NCT05517928 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT05517928 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05517928 about?

NCT05517928 is a clinical study titled "A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis". The purpose of this study is to investigate the impact of the probiotic Lactobacillus rhamnosus (LGG) on proton pump inhibitor (PPI)-induced changes to the microbes that live in the gastrointestinal tract and are passed out in the stool. PPI medicines reduce stomach acid and are commonly used to tre...

What is the current status of trial NCT05517928?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-03-03. Estimated completion is 2026-12.

What conditions does trial NCT05517928 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05517928?

The interventions under investigation include: Placebo (DRUG), Omeprazole (DRUG), Lactobacillus rhamnosus GG (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05517928?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05517928 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.